Apogee Therapeutics, Inc. (APGE) Financials

$34.55

north_east
$0.6 (1.77%)
Day's range
$32.54
Day's range
$34.95
$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80M-$100M-$100MEarning20222022202320235%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

APGE Income statement / Annual

Last year (2023), Apogee Therapeutics, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Apogee Therapeutics, Inc.'s net income was -$83.99 M. See Apogee Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022
Period Ended 12/31/2023 12/31/2022
Operating Revenue $0.00 $0.00
Cost of Revenue $0.00 $0.00
Gross Profit $0.00 $0.00
Gross Profit Ratio 0 0
Research and Development Expenses $68.42 M $27.79 M
General & Administrative Expenses $24.58 M $2.94 M
Selling & Marketing Expenses $0.00 $0.00
Selling, General & Administrative Expenses $24.58 M $2.94 M
Other Expenses $0.00 $0.00
Operating Expenses $93.00 M $30.73 M
Cost And Expenses $93.00 M $30.73 M
Interest Income $9.02 M $92,000.00
Interest Expense $0.00 $9.15 M
Depreciation & Amortization $9.02 M $33.52 M
EBITDA -$83.99 M $0.00
EBITDA Ratio 0 0
Operating Income Ratio 0 0
Total Other Income/Expenses Net $9.02 M -$9.06 M
Income Before Tax -$83.99 M -$39.79 M
Income Before Tax Ratio 0 0
Income Tax Expense $0.00 -$33,520.00
Net Income -$83.99 M -$39.79 M
Net Income Ratio 0 0
EPS -3.36 -0.79
EPS Diluted -3.36 -0.79
Weighted Average Shares Out $25.01 M $50.67 M
Weighted Average Shares Out Diluted $25.01 M $50.67 M
Link